Feili Liu

Investigation of miRNA and mRNA Co-expression Network in Ependymoma

Feili Liu, H. Dong, Ziao Mei, 2020, Frontiers in Bioengineering and Biotechnology.

MPscore: A Novel Predictive and Prognostic Scoring for Progressive Meningioma

Feili Liu, Chenkai Ma, J. Qian, 2021, Cancers.

Polymorphisms of insulin receptor substrate 2 are putative biomarkers for pediatric medulloblastoma: considering the genetic susceptibility and pathological diagnoses

Shengying Qin, Feili Liu, Jiajia Wang, 2017, Nagoya journal of medical science.

Mini-temporal approach as an alternative to the classical pterional approach for resective temporal region surgeries

Jinsong Wu, Peng Wang, Jie Zhang, 2021, Chinese Neurosurgical Journal.

Oxymatrine Inhibits Proliferation and Migration While Inducing Apoptosis in Human Glioblastoma Cells

Feili Liu, Jiajia Wang, Qifeng Li, 2016, BioMed research international.

MEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment

H. Zong, Feili Liu, Chenran Zhang, 2015, Cellular and Molecular Immunology.

MEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment

H. Zong, Feili Liu, Chenran Zhang, 2015, Cellular and Molecular Immunology.